Скачать с ютуб What is DAYBUE? - What You Need to Know About DAYBUE (trofinetide), Part 1 в хорошем качестве

What is DAYBUE? - What You Need to Know About DAYBUE (trofinetide), Part 1

In this first in our 3-part Q&A series, Dr. Dominique Pichard, IRSF Chief Science Officer, answers some of your most frequently asked questions about DAYBUE (trofinetide) in a discussion with IRSF's Tim Frank, including: - What is trofinetide and how does it work? - What were the results and side effects from the clinical trials? - What do we know now about DAYBUE, including who it's approved for, how it's administered, and how families can access it? You can find all videos in this series, plus audio-only versions and transcripts in English and Spanish, on our website at rettsyndrome.org/trofinetidevideos. Learn more about DAYBUE and register for Acadia Pharmaceuticals' March 28th webinar for caregivers at daybue.com. Find links to resources and share your reaction to this historic news on our website at rettsyndrome.org/trofinetideapproved. Make sure to like or follow our channel to be notified when the next videos in the series are available. Disclaimer: All information is intended for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your specific medical condition.